CYTR - CytRx Corporation

NasdaqCM - NasdaqCM Real-time price. Currency in USD
1.28
+0.03 (+2.40%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous close1.25
Open1.26
Bid1.20 x 800
Ask1.50 x 800
Day's range1.26 - 1.29
52-week range1.23 - 6.00
Volume98,636
Avg. volume383,110
Market cap43.056M
Beta1.31
PE ratio (TTM)N/A
EPS (TTM)-1.07
Earnings date8 May 2018 - 14 May 2018
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est4.50
Trade prices are not sourced from all markets
  • Associated Presslast month

    CytRx: 1Q Earnings Snapshot

    On a per-share basis, the Los Angeles-based company said it had a loss of 15 cents. The company's shares closed at $1.89. A year ago, they were trading at $2.95. _____ This story was generated by Automated ...

  • Associated Press3 months ago

    CytRx reports 4Q loss

    The Los Angeles-based company said it had a loss of 16 cents per share. The cancer drug developer posted revenue of $100,000 in the period. For the year, the company reported that its loss narrowed to ...

  • Associated Press7 months ago

    CytRx reports 3Q loss

    On a per-share basis, the Los Angeles-based company said it had a loss of 19 cents. Losses, adjusted for non-recurring gains, were 33 cents per share. The company's shares closed at $1.93. A year ago, ...

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes